Skip to website navigation Skip to article navigation Skip to content

A page refresh occures when a subject is selected.

Skip article navigation.

Providing access to our solutions​

Improving access to quality care and medicines for patients with epilepsy in low- and medium-income countries

Improving access to quality care and medicines for patients with epilepsy in low- and medium-income countries

Building on the experience gained through our on-going community projects in Africa and Asia, we have defined in 2020 a forward-looking framework for access and treatment for patients with epilepsy in low-and medium income countries. From now onwards, we will focus our innovation and partnership efforts on new value chain and enterprise models and start implementing a social business in 2021, focusing on two first pilots in India and Rwanda. We will report first progress on this new approach at UCB at the end of 2021.

UCB continues to focus on developing and implementing innovative, differentiated solutions that provide demonstrable value to patients – and healthcare systems around the globe – improving lives now and in the future.